Details about Federico Spandonaro

Access statistics for papers by Federico Spandonaro.

Last updated 2024-01-06. Update your information in the RePEc Author Service.

Short-id: psp73

Working Papers

2014

1. Does federalism induce patients’ mobility across regions? Evidence from the Italian experience
   DISCE - Working Papers del Dipartimento di Economia e Finanza, Università Cattolica del Sacro Cuore, Dipartimenti e Istituti di Scienze Economiche (DISCE) View citations (51)

Journal Articles

2023

1. Analysing outpatient care access for planning purposes: The Basilicata Region experience
   Evaluation and Program Planning, 2023, 99, (C) View citations (1)
2. Review and Assessment of Policy Options for Improving Access to Combination Therapies in Oncology in Europe
   Applied Health Economics and Health Policy, 2023, 21, (4), 537-546

2022

3. Pediatric growth hormone treatment in Italy: A systematic review of epidemiology, quality of life, treatment adherence, and economic impact
   PLOS ONE, 2022, 17, (2), 1-24
4. The economic burden of obesity in Italy: a cost-of-illness study
   The European Journal of Health Economics, 2022, 23, (2), 177-192 View citations (2)

2021

5. Proposte per l?attuazione del PNRR in sanit?: governance, riparto, fattori abilitanti e linee realizzative delle missioni
   MECOSAN, 2021, XXX, (119), 89-117 View citations (1)
6. Strumenti di sviluppo e di misurazione delle competenze per l?innovazione clinica: il caso della telemedicina e il caso dell?eradicazione del virus HCV
   MECOSAN, 2021, XXX, (118), 117-136

2019

7. La mobilit? transfrontaliera dei pazienti: un?analisi del fenomeno in Italia
   MECOSAN, 2019, 2019/112, (112), 61-82

2010

8. Personal Care Services in Health Economics: On the Efficiency-Equity Trade-Off
   Economia dei Servizi, 2010, (1), 63-90

2007

9. Medium Size Pharmaceutical Firms in Italy: Strategies, Performance and Prospects
   L'industria, 2007, (4), 653-678

2005

10. Dinamiche determinanti del settore farmaceutico in Europa
    L'industria, 2005, (1), 103-118
11. Riforme pro-competitive e sostenibilità nel Servizio Sanitario Italiano
    L'industria, 2005, (1), 15-36

2003

12. Strategie e performance delle grandi aziende farmaceutiche in Italia (1979-2001)
    L'industria, 2003, (2), 333-350